跳至主要内容
临床试验/EUCTR2008-005892-83-GB
EUCTR2008-005892-83-GB进行中(未招募)1 期

Does metformin improve pregnancy outcomes [ incidence of LGA (=90% birth weight centile) babies onset of maternal Gestational Diabetes, hypertension, PET, shoulder dystocia, admission to SCBU) in obese non-diabetic women? - Metformin in Obese Non-Diabetic Pregnant Women (MOP Trial)

Epsom and St Helier University Hospitals NHS Trust0 个研究点目标入组 450 人开始时间: 2009年4月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Obese pregnant women with bmi >35
  • 2. Informed written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 400
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Gestational diabetes at booking, Type I and Type II diabetes.
  • 2. Presence of contra indications to metformin (renal, liver and heart failure).
  • 3. Moving out of study area for pregnancy management.
  • 4. Participants who suffer with hyperemesis.
  • 5. Participants who are 18 years and below.
  • 6. Participants with high alcohol intake.

研究者

相似试验